Want to see CAH full AI Analyst Report?
Operating Expense Breakdown
Details core costs like R&D, marketing, and admin, offering insight into how efficiently the company runs and where it’s prioritizing investment.Cardinal Health's operating expenses have seen a notable increase, particularly in Distribution, Selling, General, and Administrative costs, which surged in 2025. This aligns with the company's robust revenue and profit growth across all segments, as reported in the latest earnings call. The acquisition of Solaris Health is expected to further boost the Pharmaceutical segment's profitability. However, rising interest expenses and tariff costs could pose challenges. The company remains optimistic, raising its EPS guidance and projecting strong cash flow, reflecting confidence in strategic execution.
Date | Distribution, Selling, General, and Administrative | Restructuring and Employee Severance | Amortization and Other Acquisition-Related Costs | Impairments and (Gain)/Loss on Disposal of Assets, Net | Litigation Charges, Net |
|---|---|---|---|---|---|
Jun 30, 2026 | $1.63B | $40.00M | $121.00M | $4.00M | -$3.00M |
Mar 31, 2026 | $1.54B | $25.00M | $114.00M | $185.00M | $11.00M |
Dec 31, 2025 | $1.50B | $21.00M | $130.00M | -$14.00M | -$18.00M |
Sep 30, 2025 | $1.46B | $20.00M | $104.00M | $2.00M | $0.00 |
Jun 30, 2025 | $1.48B | $27.00M | $133.00M | $33.00M | -$9.00M |
Mar 31, 2025 | $1.31B | $28.00M | $152.00M | -$17.00M | -$105.00M |
Dec 31, 2024 | $1.31B | $9.00M | $105.00M | $3.00M | -$31.00M |
Sep 30, 2024 | $1.28B | $24.00M | $74.00M | -$1.00M | -$40.00M |
Jun 30, 2024 | $1.28B | $69.00M | $77.00M | $8.00M | $50.00M |
Mar 31, 2024 | $1.28B | $53.00M | $80.00M | $84.00M | $81.00M |